Prosecution Insights
Last updated: October 26, 2026

Terra C Gibbs, USPTO Patent Examiner

Listed by the USPTO as GIBBS, TERRA C

Tech Center 4100 • Art Units: 1635 1653 1674 4100

This examiner grants 64% of resolved cases

Analysis

GIBBS, TERRA C works in Technology Center 4100 and Art Unit 1635. The profile covers 969 resolved cases, with an allowance rate of 63.7% and a median of 994 days to allowance. The interview lift is 10.4%, indicating a positive relationship between interviews and allowance outcomes in the available cases.

The principal companies are Flagship Pioneering Inc., Alnylam Pharmaceuticals Inc., and Beam Therapeutics Inc. The leading firms are MCCARTER & ENGLISH, LLP, Morgan, Lewis & Bockius LLP (WA), and pH IP Law. The record supports a prosecution approach that combines substantive claim refinement with deliberate interview use. The company and firm affiliations point to biotechnology matters where applicants may need to explain technical distinctions clearly while managing a median timeline approaching the stated pendency measure.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

63.7%
Allow Rate
+3.7% vs TC avg
1,014
Total Applications
+10.4%
Interview Lift
994
Avg Prosecution Days
Based on 969 resolved cases, 2023–2026

Rejection Statute Breakdown

6.2%
§101 Eligibility
18.0%
§102 Novelty
34.8%
§103 Obviousness
28.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18259098 VIRAL CAPSID PROTEINS WITH SPECIFICITY TO HEART TISSUE CELLS Non-Final OA Boehringer Ingelheim International GmbH
18289418 MIRNA INHIBITORS FOR PREVENTING AND TREATING ANEURYSMS, HYPERTENSION, ARDS AND OTHER DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION Non-Final OA The Regents of the University of California
18560347 COMPOSITIONS AND METHODS OF TARGETING THE PAX6 SIGNALING PATHWAY TO REDUCE FORMATION OF AMYLOID BETA PLAQUES AND NEUROFIBRILLARY TANGLES Non-Final OA The University of Hong Kong

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Terra C Gibbs's allowance rate?

63.7% of resolved applications examined by Terra C Gibbs were allowed (969 resolved cases), compared with 51.6% across Art Unit 1635 over the last five years.

Does an interview help with examiner Terra C Gibbs?

This examiner's interview lift is +10.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Terra C Gibbs take to allow a patent?

Applications allowed by Terra C Gibbs took 994 days on average from filing to allowance.

Which art unit does examiner Terra C Gibbs work in?

Terra C Gibbs examines applications in Art Unit 1635 in Tech Center 4100.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month